What the U.S. may target is a dismantling, or watering down, of restrictions with respect to NHS price setting and reimbursement of pharmaceuticals and medical devices.
As Brexit Nears, Fears Of An NHS Sell-Out Resurface
What the U.S. may target is a dismantling, or watering down, of restrictions with respect to NHS price setting and reimbursement of pharmaceuticals and medical devices.